The FDA approved a new pill called Nereus (tradipitant) that can prevent vomiting caused by motion sickness. In clinical trials, Nereus helped up to 90 percent of people prone to motion sickness avoid ...

What Is Nereus, And Why Does It Matter? Nereus (tradipitant) is a new prescription medicine approved by the FDA to help prevent nausea and vomiting caused by motion (motion sickness) in adults, such ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Nereus is the first new pharmacologic treatment for motion sickness approved in over four decades, highlighting a significant advancement in the field. Motion sickness affects military operations and ...

Add Yahoo as a preferred source to see more of our stories on Google. The US Food and Drug Administration (FDA) has approved Vanda Pharmaceuticals’ Nereus (tradipitant) for the prevention of vomiting ...

Vanda Pharmaceuticals is buy-rated following FDA approval of Nereus for motion sickness, with shares offering upside into 2026 catalysts. VNDA's Q3 saw strong Fanapt sales growth, but higher R&D and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

An asteroid that is roughly the size of the Eiffel Tower is nearing Earth's orbit this month. The giant space rock is also estimated to be comprised of precious metals worth nearly $5 billion dollars.